Changes in Utilization and Costs for Patients with Rheumatoid Arthritis, 1997 to 2006

Author： Birnbaum Howard G.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.30, Iss.4, 2012-04, pp. : 323-336

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Direct medical costs and their predictors in patients with rheumatoid arthritis

By  

Arthritis & Rheumatism, Vol. 48, Iss. 10, 2003-10 ,pp. : 2750-2762

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early changes in bone metabolism in rheumatoid arthritis patients treated with infliximab

By  

Arthritis & Rheumatism, Vol. 48, Iss. 10, 2003-10 ,pp. : 2996-2997

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tacrolimus: In Patients with Rheumatoid Arthritis

By Curran Monique P.   Perry Caroline M.  

Drugs, Vol. 65, Iss. 7, 2005-01 ,pp. : 993-1001

Adis International

Access to resources Recommend Favorite

Biologic Battlefields: Changes in the US Markets for Rheumatoid Arthritis and Psoriatic Arthritis

By  

Pharmaceutical & Diagnostic Innovation, Vol. 1, Iss. 3, 2004-01 ,pp. : 16-20

Adis International

Access to resources Recommend Favorite

Ofatumumab offers hope for patients with rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1662, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite